🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › Illinois › Evanston

Etid klinik pou Limfom Difize Gwo Selil B nan Evanston, IL

3 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Evanston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Ap rekriteFaz 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06649812

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Ap rekriteFaz 2/3
  • Illinois Cancer Specialists ( Site 8000), Niles · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05139017

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • Northwestern University, Evanston
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07284433

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Evanston

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.